Earlier on January 17, Brottem acquired 9,090 common shares at no cost as part of performance-based restricted stock units, which are granted based on meeting specific performance criteria. After these transactions, Brottem holds 181,188 Outset shares Medical (TASE:) directly. The company maintains a strong liquidity position with a current ratio of 6.49, indicating good short-term financial health. For a comprehensive analysis of insider trading and 12 additional key insights about Outset Medical, visit InvestingPro. The company maintains a strong liquidity position with a current ratio of 6.49, indicating good short-term financial health. For a comprehensive analysis of insider trading and 12 additional key insights about Outset Medical, visit InvestingPro.
Earlier on January 17, Brottem acquired 9,090 common shares at no cost as part of performance-based restricted stock units, which are granted based on meeting specific performance criteria. Following these transactions, Brottem directly holds 181,188 shares of Outset Medical.
“In other recent news, Outset Medical, Inc. reported strong results for the third quarter of 2024, with revenue reaching $28.7 million, exceeding guidance. Treatment revenue increased by 14% and service revenue by 22%.Despite a net loss of $20.2 million, this was an improvement over the previous year, and the company’s gross margin increased to 36.4%.The company also increased its 2024 revenue to approximately $112 million.
At the same time, Outset Medical completed a private placement offering and issued non-voting Series A convertible preferred shares. The company also borrowed $100 million as an initial term loan from Perceptive Credit Holdings IV, LP, and issued a warrant to purchase more than 5 million shares of its common stock.
On the analyst side, BTIG analyst Maria Thibault revised her price target on Outset Medical to $3.00, down from the previous $4.00, while maintaining a buy rating on the stock. These are recent developments that investors should be aware of.”
This article was generated with the help of AI and reviewed by an editor. See our T&C for more information.
